CurrentCardio
Get Weekly

Topic · page 32 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,241–1,280 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. J Am Coll Cardiol

    Association of Systemic Thromboxane Generation With Risk of Developing Heart Failure

    Cohort study

  2. Nat Med

    Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial

    Randomised controlled trial

  3. JAMA Cardiol

    Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Cohort study

  4. JAMA Cardiol

    Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  5. JAMA Cardiol

    Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Secondary analysis

  6. JAMA Cardiol

    Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy

    Cohort study

  7. Eur J Heart Fail

    The Transcriptional Profile of Iron Deficiency in Patients with Heart Failure: Heme-Sparing and Reduced Immune Processes

    Mechanistic study

  8. Eur J Heart Fail

    Empagliflozin in Acute Myocardial Infarction in Patients with and Without Type 2 Diabetes: A Pre-Specified Analysis of the EMPACT-MI Trial

    Secondary analysis

  9. Eur J Heart Fail

    Observational Study for Multiparametric Assessment of Cardiac Congestion in Outpatient Worsening Heart Failure (EVOLUTION)

    Cohort study

  10. Eur J Heart Fail

    Guideline-Directed Medical Therapy for Heart Failure in Arrhythmia-Induced Cardiomyopathy with Improved Left Ventricular Ejection Fraction

    Cohort study

  11. JACC Heart Fail

    Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device

    Secondary analysis

  12. Eur J Heart Fail

    Association Between Body Mass Index and Clinical Outcomes in Patients with Acute Myocardial Infarction and Reduced Systolic Function: Analysis of PARADISE-MI Trial Data

    Secondary analysis

  13. Eur J Heart Fail

    The Risk of Death According to Left Ventricular Ejection Fraction and Right Ventricular Dilatation in 17 321 Adults with Heart Failure from 40 High-, Middle- and Low-Income Countries – A Global Congestive Heart Failure (G-CHF) Study

    Cohort study

  14. Eur J Heart Fail

    Effect of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction Across the Age Spectrum in PARAGON-HF

    Secondary analysis

  15. Eur J Heart Fail

    Empagliflozin to Prevent Worsening of Left Ventricular Volumes and Systolic Function After Myocardial Infarction (EMPRESS-MI)

    Randomised controlled trial

  16. Eur J Heart Fail

    End-organ Protective Effect of Serelaxin in Patients Hospitalized for Heart Failure: Results of the Biomarker Substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)

    Secondary analysis

  17. J Am Coll Cardiol

    Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HF

    Secondary analysis

  18. Eur J Heart Fail

    Machine Learning Approach to Identify Phenotypes in Patients with Ischaemic Heart Failure with Reduced Ejection Fraction

    Secondary analysis

  19. Eur J Heart Fail

    Long-Term Rate of Heart Failure in Patients with Autoimmune Disease: A Nationwide Cohort Study

    Cohort study

  20. Eur J Heart Fail

    Endomyocardial Biopsy in the Diagnosis of Cardiac Sarcoidosis

    Cohort study

  21. Eur J Heart Fail

    Outpatient Worsening of Heart Failure and Mortality in Transthyretin Amyloid Cardiomyopathy

    Cohort study

  22. Circulation

    Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy

    Diagnostic or prognostic study

  23. JACC Cardiovasc Imaging

    Leveraging a Vision Transformer Model to Improve Diagnostic Accuracy of Cardiac Amyloidosis With Cardiac Magnetic Resonance

    Diagnostic or prognostic study

  24. Eur Heart J

    Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular Genomics

    Guideline or statement

  25. Eur J Heart Fail

    Diuretic Efficiency of a Single Dose of Subcutaneous Versus Oral Furosemide After Heart Failure Hospitalization Across Diuretic Resistance Strata: A Pilot Randomized Controlled Trial

    Randomised controlled trial

  26. JAMA Cardiol

    Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3

    Cross-sectional study

  27. JAMA Cardiol

    Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial

    Randomised controlled trial

  28. JAMA Cardiol

    Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure

    Research article

  29. Eur J Heart Fail

    Associations of Iron Deficiency with Cardiac Function, Congestion, Exercise Capacity and Prognosis in Heart Failure

    Cohort study

  30. JACC Heart Fail

    Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional Outcomes

    Secondary analysis

  31. JACC Heart Fail

    Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial

    Secondary analysis

  32. Eur J Heart Fail

    Mesenchymal Precursor Cells Reduce Mortality and Major Morbidity in Ischaemic Heart Failure with Inflammation: DREAM-HF

    Secondary analysis

  33. Eur J Heart Fail

    Discontinuation and Reinitiation of Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction

    Cohort study

  34. Eur J Heart Fail

    State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases

    Guideline or statement

  35. Eur J Prev Cardiol

    Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study

    Cohort study

  36. Circulation

    Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS

    Cohort study

  37. JACC Heart Fail

    The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation

    Secondary analysis

  38. JACC Heart Fail

    Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial

    Secondary analysis

  39. Eur J Heart Fail

    Effects of Sacubitril/Valsartan According to Background Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF

    Secondary analysis

  40. Eur J Heart Fail

    Knowledge and Application of ESC/HFA Guidelines in the Management of Advanced Heart Failure

    Cross-sectional study

All 1,928 Briefs in ExploreShowing Briefs 1,241–1,280 of 1,928, newest first